$20.35
1.276.66%
Last update: Nov 6, 7:40 PM
Structure Therapeutics Inc
GPCRNASDAQ
Structure Therapeutics (GPCR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.38 | $-0.33 | $-0.36 | $-0.36 |
| Actual | $-0.49 | $-0.35 | $-0.36 | $-0.37 |
| Surprise | -28.9% | -6.06% | 0.00% | -2.78% |
| Revenue | ||||
| Estimate | — | $11.1M | $200.0M | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | -100.0% | -100.0% | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.29 | $-0.49 | $-0.48 | $-0.50 |
| Revenue | ||||
| Consensus | $50.0M | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.49 | $-0.38 | -28.9 % |
| Q1 | May 7, 2026 | $-0.35 | $-0.33 | -6.06 % |
| Q4 | Feb 26, 2026 | $-0.36 | $-0.36 | 0.00 % |
| Q3 | Nov 6, 2025 | $-0.37 | $-0.36 | -2.78 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 7, 2026 | $0 | $11.11M | -100.0 % |
| Q4 | Feb 26, 2026 | $0 | $200.00M | -100.0 % |
